News | Artificial Intelligence | April 11, 2023

Acarix Accelerates US Commercialization into 30 Additional States

The new partnership expands Acarix sales organization with 16 additional sales teams covering initially 30 new states across the United States

The new partnership expands Acarix sales organization with 16 additional sales teams covering initially 30 new states across the United States

April 11, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced a strategic sales partnership with CompleMed, LLC, a national sales organization focusing on the US cardiology market. This partnership expands Acarix sales organization with 16 additional sales teams covering initially 30 new states across the United States, reaching a current geographic market coverage of 43 states. 

"We are thrilled to be collaborating with Acarix, whose reputation in the US market continues to grow”, stated Mike Buie, President of CompleMed. “The CADScor System has captured our attention as an exceptional solution for early assessment of patients with non-acute chest pain, which is an increasingly complex and resource demanding issue in the US healthcare system. We look forward to making a difference together with the Acarix team." 

"We are excited to announce our new partnership with CompleMed, whose sizeable and capable sales team will enable us to expand our geographic coverage rapidly into additional states. We are eager to expand our US footprint to continue to build on our momentum and bring the CADScor System to even more patients. This well-planned expansion aligns well with our growth strategy and reaffirms our commitment to delivering exceptional care to patients." said Acarix President & CEO, Helen Ljungdahl Round

For more information: www.acarix.com 

Related Content: 

Study published in Heart strengthens diagnostic value of Acarix CADScor System 
Acarix Presents CADScor System at ESC 2018 


Related Content

News | Cardiovascular Business

February 22, 2024 — Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the ...

Home February 22, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

It is a new year with lots of new content! Here is a look at the most-read content during the month of January on ...

Home February 01, 2024
Home
Feature | Cardiovascular Business

Did you know that Diagnostic and Interventional Cardiology (DAIC) maintains more than 40 comparison charts of product ...

Home January 29, 2024
Home
News | Cardiovascular Business

January 24, 2024 — Medtronic announced the recent appointment of Simona Zannetti, MD, as the General Manager of its ...

Home January 24, 2024
Home
News | Cardiovascular Business

January 22, 2024 — The American College of Cardiology is again urging members of Congress to retroactively eliminate the ...

Home January 22, 2024
Home
News | Cardiovascular Business

January 22, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods ...

Home January 22, 2024
Home
News | Cardiovascular Business

January 22, 2024 — Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently ...

Home January 22, 2024
Home
News | Cardiovascular Business

January 12, 2024 — The Heart Surgeon’s Cookbook is the brainchild of New York-based Cardiovascular and Thoracic Surgeon ...

Home January 12, 2024
Home
News | Cardiovascular Business

January 8, 2024 — GE HealthCare announced it has entered into an agreement to acquire MIM Software, a global provider of ...

Home January 08, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As the Diagnostic and Interventional Cardiology (DAIC) team welcomes in the New Year, we also have taken a few moments ...

Home January 05, 2024
Home
Subscribe Now